CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune check ...
Phase 1, Phase 2
Duarte, California, United States and 19 other locations
This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...
Phase 2
Los Angeles, California, United States and 66 other locations
Study RGX-104-001 is a Phase 1, first-in-human, dose escalation and expansion study of RGX-104, an oral small molecule targeting the liver X receptor...
Phase 1
Los Angeles, California, United States and 20 other locations
Phase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-002 given intravenously every 3 weeks.
Phase 1
Los Angeles, California, United States and 26 other locations
IMGN151-1001 is a Phase 1, first in human, open-label dose-escalation and expansion study in adult patients with recurrent endometrial cancer...
Phase 1
Los Angeles, California, United States and 5 other locations
This phase II trial studies how well abemaciclib works in treating patients with ovarian or endometrial cancer that has an activati ...
Phase 2
Los Angeles, California, United States
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
Newport Beach, California, United States and 162 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Beverly Hills, California, United States of America and 75 other locations
This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in...
Phase 2
Los Angeles, California, United States and 11 other locations
choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...
Phase 3
Santa Monica, California, United States and 168 other locations
Clinical trials
Research sites
Resources
Legal